Advanced. Metastatic. Rare. Aggressive. Not exactly words you want to hear about your solid-tumor cancer. But when you hear that your tumor tissue has been sent out for genomic profiling, you can feel good knowing that you’re getting useful information.
For patients with advanced, metastatic, rare, or aggressive cancer
The OncoExTra test takes a thorough look at genes within your tumor, giving you and your doctor personalized insights into which treatment options may be best for you.
The OncoExTra test looks at the gene mutations in your tumor to help determine which treatments, immunotherapies, and clinical trials are most appropriate for you. Get an understanding of the testing process, learn what you can expect from the results, and explore FAQs.